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1153-88 VLDL LIpoprotein and Triglyceride Clearance by the 
Lung Is Markedly Reduced in Congestive Heart Failure 
Alistair I. Fvfe. J Edward Rosenthal, Bonnie L. Floyd, David L. Brown, Ronald H. 
Underwood, Medical City Dallas Hospital, Dallas, Texas. 
Simultaneous measurement of 16 lipoprotain particle concentrations in the right atrium 
and aortic root allow calculation of organ and circulation specific metabolism of individual 
particles. Initial studies showed consistent and significant reductions in plasma triglycer- 
ida (TG), and VLDL concentrations after passage through the lungs. 
METHODS:Plasma was simultaneously sampled from the right atrium and aortic root in 
26 patients undergoing combined right and left heart catheterization (16 Congestive 
heart failure (CHF), 9 Transplant/Valvular). Samples were analyzed using NMR spectros- 
copy (LipoMed) into chytomicrons, 6 VLDL sub-classes, IDL, 3 LDL subclasses and 5 
HDL subclasses. Arterio-venous differences and clearance rates were calculated using 
hemodynamic information and thermodilution cardiac output, Paired t tests and logistic 
regression analysis were used to determine contributors to lipoprotein particle metabo- 
lism. 
RESULTS: There is significant removal of triglyceride from VLDL during passage through 
the lungs, venous blood contains 90±13 mg/dl compared to 78±12 mg/dl in arterial 
blood,(p<0.005). Specifically large VLDL 5+6 particles are reduced during passage 
through the lung from 22±5 to 9±3 mg/dl, p=0.01. Removal of TG from VLDL was 
reduced by 90% in patients with a current history of CHF; 110±14 vs 1276±197 mg/min 
(p<0.0003). There was no relationship between VLDL and VLDL TG metabolism and 
right atrial pressure or wedge pressure. There was no difference in VLDL metabolism 
between post-transplant and valvular patients. 
CONCLUSIONS: These data confirm that the pulmonary circulation removes a signifi- 
cant amount of VLDL triglyceride, specifically from VLDL 5+6 particles during transit and 
that this removal is markedly reduced in patients with congestive heart failure, This 
abnormality reverts to normal after transplantation. 
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1154-77 Microalbuminuria Accompanies Concentric Type of  Left  
Ventricular Geometric Pattern in Untreated Essential 
Hypertensive Subjects 
Costas Tsioufis, C. Stafanadis, D, Antoniedis. I. Kallikazaros, T, Psaros, S. Lalos, C. 
Pitsavos, V, Papedemetdou, P. Toutouzas, University of Athens, Hippokratio Hospital, 
Athens, Greece, VAMC & Georgetown University Medical Centers, Washington DC. 
Background: A slight elevated urinary albumin excretion (UAE) is welt related with other 
target-organ damage. However the interaction between microalbuminuria (MA) and the 
spectrum of left ventricular (LV) geometric pattern in hypertension has not been well 
defined. 
Methods: For this purpose, MA was determined in 3 non-consecutive 24-h udne samples 
as UAE of 20-200mg/24h in a group of 249 untreated hypertensive subjects. Echocardio- 
graphic classification of patients into LV geometric patterns was based on relative wall 
thickness values and on gender specific values for LV mass index (LVMI). 
Results: The group of patients with MA (n=119) was matched for demographics with 
those without MA (n=130). Subjects with MA had significantly increased LVMI (111 vs 90 
g/m2, p<0.0001), relative wail thickness (0.46 vs 0.41, p<0.001) and office BP (161/ 
101vs148/97 mmHg, p<0.005). UAE was positively correlated to LVMI (r=0.46, p<0.O01) 
and relative wall thickness (r=0.47, p<0.001). LV normal geometry (LV-NG), LV concen- 
tric remodeling (LV-CR), LV eccentric and concentric hypertrophy (LV-EH, LV-CH) was 
found in 34%, 33%, 12% and 21%, respectively. The incidence of LV-NG was signifi- 
cantly higher in normoalbuminudc compared to mlcroalbumnudc subjects (55 vs 14%, 
p<0.001) while the incidence of LV-CH was significantly higher in microatbuminuric om- 
pared to normoalbuminudc subjects (32 vs 5%, p<0.001). Multiple regression analysis 
revealed that LV-CH was significantly associated with increased values of UAE and 
mean arterial pressure. 
Conclusions: The higher prevalence of unfavorable LV geometric patterns in hyperten- 
sive subjects with MA compared to those without MA, may account for the worse cardio- 
vascular outcomes associated with the presence of an increased UAE in hypertensive 
subjects. 
1154-78 Pulsed Tissue Doppler Distinguishes Difference of 
Longitudinal Myocardial Function Between Ath let ic  and 
Hypertensive Left Ventricular Hypertrophy 
Maudzio Galderisi. Antonello D'Andree, Pio Caso, Debora Di Maggio, Annibale Izzo, 
Silvana Cicala, Marino Schedllo, NicoJa Mininni, Raffaele Calabro', Oresta de Divitiis, 
Mona/di Hospital, Naples, Italy, Federico /I Universi~ naples, Italy. 
Aim of the study: to analyze difference of longitudinal myocardial function between ath- 
letic and hypertensive left ventricular (LV) hypertrophy. 
Methods: Standard Doppler echo and pulsed "Tissue Doppler (TD) of posterior sepum 
and inferior wall (apical view) were performed in 20 competitive endurance athletes 
(water-polo players) (AT) and in 22 hypertensives (HT), all men, both having LV hypertro- 
phy (LV mass index > 50 g/m2,7). By TD, the following measurements of myocardial lon- 
gitudinal function were assessed for each walt: systolic peak velocities (Sin), pre- 
contraction time (PCTm), contraction time (CTm), early (Era) and late (Am) diastolic peak 
velocities, Em/Am ratio, relaxation time (RTm). 
Results: HT showed higher age, body mass index (BMI), heart rate (HR) and blood pres- 
sure than AT. LV mass index (61.4 ± 9.9 g/m2.7 in AT vs. 62.2 ± 8.7 g/m2.7 in HT, NS) 
and relative wall thickness were comparable between the 2 groups. After adjusting for 
age, HR and mean blood pressure, andocardial fractional shortening and all Doppler 
diastolic indexes ware impaired in HT while TD showed lower Sm, Em and Em/Am ratio 
and longer RTm, PCTm and CTm, of both septal and inferior walls in HT. A cut-off point 
of transmitral E peak velocity < 0.74 m/s had a sensitivity of 72.7 % and a specificity of 85 
% while a TD infador Em peak velocity < 0.16 m/sec differentiated better AT and HT 
(sensitivity = 100 %, specificity = 95 %). After adjusting for HR, age and LV mass index 
by separate multilinear regression analyses, Em peak velocity of inferior wall had an 
independent positive association with LV end-diastolic diameter (13 coefficient = 0.72, 
p<0.001) in AT and an independent inverse association with LV end-systolic stress (13 = - 
0.62, p<0.001) in HT. 
Conclusions: TD identifies mechanisms underlying difference of myocardial function 
between athletic and hypertensive LV hypertrophy. Early diastolic myocardial function is 
positively influenced by preload increase in AT and negatively related to increased after- 
load in HT. TD may be useful to differentiate physiologic and pathologic LV hypertrophy 
better than standard Doppler achocardiography. 
1154-79 Are Left  Ventricular Mass, Geometry, and Function 
Related to  Vascular Changes and/or Insulin Resistance 
in Longstanding Hypertension? A LIFE Subetudy 
Michael H. Olsen. Elsa Hjerkinn, Kristian Wachtall, Aud H~iggen, Jonathan N. Bella, 
Shawna D. Nesbitt, Eigil Fossum, Sverre E. Kjeldsan, Richard B. Devereux, Stevo Julius, 
Hans ibsen, Glostrup University Hospital, Copenhagen, Denmark, Ullevaal University 
Hospital, Oslo, Norway. 
Background: Vascular hypertrophy and insulin resistance have been associated with 
abnormal left ventdcular (LV) geometry, while a possible association to abnormal LV 
function is less investigated. 
Methods: In 89 patients with essential hypertension and electrocardiographic LV hyper- 
trophy, we measured after two weeks of placebo treatment blood pressure, insulin sensi- 
tivity by hyperinsulinemic euglucemic clamp, minimal forearm vascular resistance 
(MFVR) by plathysmography, intima media cross-sectional area of the common carotid 
arteries lIMA) by ultrasound, LV mass, relative wall thickness (RWT), systolic function 
and diastolic filling by eohocardiography, 
Results: LV mass index correlated to IMA/height (r=0.36, P--0.001), serum insulin (r=- 
0.25, P<0.05), plasma glucose (r=-0.34, P<0.01), and showed a tendency towards a cor- 
relation to insulin sensitivity (r=0.21, P=0.051 ), but was unrelated to MFVR. Deceleration 
time of early diastolic transmittal flow correlated positively to IMA/height (r=0.30, 
P<0.01), The ratio between early and atrial LV filling peak velocity correlated negatively 
to MFVRmen (r=-0,30, P<0.05). Endocardial and midwall systolic LV function were not 
related to vascular hypertrophy, plasma glucose, serum insulin or insulin sensitivity, 
Conclusions: High thickness of the common carotid arteries was associated with LV 
hypertrophy and longer deceleration time of early diastolic transmittal flow. High MFVR 
was associated with low ratio between early and atrial LV filling peak velocity, This may 
suggest that systemic vascular hypertrophy contribute to abnormal diastolic LV relaxation 
in patients with hypertension and electrocardiographic LV hypertrophy. However, insulin 
resistance was not related to LV hypertrophy or reduced LV function in this population. 
1154-80 Safety  and Efficacy of Enhanced External  
Counterpulsation in Hypertensive Patients With 
Refractory Angina Pectoris: Short- and Long-Term 
Follow-Up 
Rohit R. Arora. James Orlando, Andrea Malone, Raghu Bejjanki, Michael Caducci, Lisa 
Kennard, University of Medicine and Dentistry of New Jersey-New Jersey Medical 
School, Newark, New Jersey, University of Pittsburgh-Graduate School of Public Health, 
Pittsburgh, Pennsylvania. 
Background: The safety and efficacy of EECP in patients with refractory angina pectons 
has been well studied. However the physiological beneficial effects may be secondary to 
reduction of systolic vascular resistance and afterload. Hypertensive patients therefore 
may proportionately derive enhanced clinical benefit. 
Methods: This study examined 1995 patients enrolled in the International EECP Patient 
Registry who received an average of 35 hours of EECP treatment. 1353 patients (67.8%) 
were hypertensive (HTN). This group had a lower proportion of white males. They were 
more likely to have had prior PCI, CHF, DM, hyperlipidemia, and family history of CAD. 
HTN patients had more severe angina and used more nitrates. They also were more 
likely to use beta blockers, calcium channel blockers, and ACE inhibitors. 
Results: EECP produced less diastolic augmentation in the HTN group. However at the 
end of treatment he HTN group showed similar reduction in anginal symptoms with 
72.8% of HTN vs. 74.9% of non-HTN showing a decrease in at least one CCSC class. 
Reduction of nitroglycerin use however was less in the HTN; 52.7% of HTN using at 
baseline were no longer using vs. 60.5% of non-HTN (p<.05). Adverse cardiac events 
during the treatment period were extremely low in both groups, although HTN patients 
were significantly more likely to have exacerbation of congestive heart failure, and epi- 
sodes of unstable angina. At six months the angina reduction was maintained similarly in 
both groups with 81% maintaining the reduction seen at post-EECP therapy. HTN 
patients did not show an increased rate of six month MACE but MI, congestive heart fail- 
ure, unstable angina, and repeat EECP were all significantly higher than in the nonoHTN 
group. 
Conclusion: EECP therapy is safe and effective in hypertensive patients with achieve- 
ment of similar reduction in angina to non-HTN group, however there is a slight increase 
in some adverse effects both in short-tarm and long-term. 
